How to Evolve and Mature Tech for Biotech and Pharma

Everyone always hears about the latest technology buzzwords and the great promise they hold, from the cloud to AI and machine learning to blockchain. But while their potential applications can often leave the most tech-savvy of us salivating, companies often want and need to know how those technologies can be used to help right now.

In the third part of our three series podcast with Vineti, Chief Technology Officer Phil Calvin speaks about the technology that most excites him and how the industry can already benefit from its use. Not only that, but he explains how life sciences companies can help to mature these technologies so they can better use them without worrying about the need to work out the kinks. In other words, he explains the optimal strategies to help implement these technologies for your company.

Listen below or catch up on the previous parts of the series: “Industrializing Personalized Therapeutics: Can You Really “Mass Customize” Patient-specific Pharmaceuticals?” and “Lessons Learned: What to Know About Producing Personalized Therapies.”

Featuring: Phil Calvin, Chief Technology Officer, Vineti

Sign up to listen to the podcast.